220 related articles for article (PubMed ID: 36192536)
1. Multiple phage resistance systems inhibit infection via SIR2-dependent NAD
Garb J; Lopatina A; Bernheim A; Zaremba M; Siksnys V; Melamed S; Leavitt A; Millman A; Amitai G; Sorek R
Nat Microbiol; 2022 Nov; 7(11):1849-1856. PubMed ID: 36192536
[TBL] [Abstract][Full Text] [Related]
2. Insights into the modulation of bacterial NADase activity by phage proteins.
Yin H; Li X; Wang X; Zhang C; Gao J; Yu G; He Q; Yang J; Liu X; Wei Y; Li Z; Zhang H
Nat Commun; 2024 Mar; 15(1):2692. PubMed ID: 38538592
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for phage-mediated activation and repression of bacterial DSR2 anti-phage defense system.
Zhang JT; Liu XY; Li Z; Wei XY; Song XY; Cui N; Zhong J; Li H; Jia N
Nat Commun; 2024 Mar; 15(1):2797. PubMed ID: 38555355
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of bacterial DSR2 anti-phage defense and viral immune evasion.
Huang J; Zhu K; Gao Y; Ye F; Li Z; Ge Y; Liu S; Yang J; Gao A
Nat Commun; 2024 May; 15(1):3954. PubMed ID: 38729958
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
Avalos JL; Bever KM; Wolberger C
Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Distinct Responses to Low NAD
Humphrey KM; Zhu L; Hickman MA; Hasan S; Maria H; Liu T; Rusche LN
Genetics; 2020 Apr; 214(4):855-868. PubMed ID: 32071196
[TBL] [Abstract][Full Text] [Related]
7. Human Sir2 and the 'silencing' of p53 activity.
Smith J
Trends Cell Biol; 2002 Sep; 12(9):404-6. PubMed ID: 12220851
[TBL] [Abstract][Full Text] [Related]
8. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition.
Sauve AA; Moir RD; Schramm VL; Willis IM
Mol Cell; 2005 Feb; 17(4):595-601. PubMed ID: 15721262
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
Zhao K; Harshaw R; Chai X; Marmorstein R
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
[TBL] [Abstract][Full Text] [Related]
10. Isonicotinamide enhances Sir2 protein-mediated silencing and longevity in yeast by raising intracellular NAD+ concentration.
McClure JM; Wierman MB; Maqani N; Smith JS
J Biol Chem; 2012 Jun; 287(25):20957-66. PubMed ID: 22539348
[TBL] [Abstract][Full Text] [Related]
11. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
Sauve AA; Schramm VL
Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
[TBL] [Abstract][Full Text] [Related]
12. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
Khan AN; Lewis PN
J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
Bitterman KJ; Anderson RM; Cohen HY; Latorre-Esteves M; Sinclair DA
J Biol Chem; 2002 Nov; 277(47):45099-107. PubMed ID: 12297502
[TBL] [Abstract][Full Text] [Related]
14. Yeast Tdh3 (glyceraldehyde 3-phosphate dehydrogenase) is a Sir2-interacting factor that regulates transcriptional silencing and rDNA recombination.
Ringel AE; Ryznar R; Picariello H; Huang KL; Lazarus AG; Holmes SG
PLoS Genet; 2013; 9(10):e1003871. PubMed ID: 24146631
[TBL] [Abstract][Full Text] [Related]
15. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
Sauve AA; Schramm VL
Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
[TBL] [Abstract][Full Text] [Related]
16. Short prokaryotic Argonautes provide defence against incoming mobile genetic elements through NAD
Zaremba M; Dakineviciene D; Golovinas E; Zagorskaitė E; Stankunas E; Lopatina A; Sorek R; Manakova E; Ruksenaite A; Silanskas A; Asmontas S; Grybauskas A; Tylenyte U; Jurgelaitis E; Grigaitis R; Timinskas K; Venclovas Č; Siksnys V
Nat Microbiol; 2022 Nov; 7(11):1857-1869. PubMed ID: 36192537
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+.
Belenky P; Racette FG; Bogan KL; McClure JM; Smith JS; Brenner C
Cell; 2007 May; 129(3):473-84. PubMed ID: 17482543
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into mechanisms of Argonaute protein-associated NADase activation in bacterial immunity.
Wang X; Li X; Yu G; Zhang L; Zhang C; Wang Y; Liao F; Wen Y; Yin H; Liu X; Wei Y; Li Z; Deng Z; Zhang H
Cell Res; 2023 Sep; 33(9):699-711. PubMed ID: 37311833
[TBL] [Abstract][Full Text] [Related]
19. Enforcement of a lifespan-sustaining distribution of Sir2 between telomeres, mating-type loci, and rDNA repeats by Rif1.
Salvi JS; Chan JN; Pettigrew C; Liu TT; Wu JD; Mekhail K
Aging Cell; 2013 Feb; 12(1):67-75. PubMed ID: 23082874
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of functional sirtuin chromatin targets in yeast.
Li M; Valsakumar V; Poorey K; Bekiranov S; Smith JS
Genome Biol; 2013 May; 14(5):R48. PubMed ID: 23710766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
